List of Excipients in API human immunoglobulin g
✉ Email this page to a colleague
Detailed excipient profiles for human immunoglobulin g
Excipient focus: ACETATE ION
human immunoglobulin g drug variants containing ACETATE ION
| Company | Ingredient | NDC |
|---|---|---|
| Bio Products Laboratory Limited | human immunoglobulin g | 64208-8235 |
| >Company | >Ingredient | >NDC |
human immunoglobulin g drug variants not containing ACETATE ION
Excipient focus: ALBUMIN HUMAN
human immunoglobulin g drug variants containing ALBUMIN HUMAN
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring AG | human immunoglobulin g | 44206-436 |
| >Company | >Ingredient | >NDC |
human immunoglobulin g drug variants not containing ALBUMIN HUMAN
Excipient focus: GLYCINE
human immunoglobulin g drug variants containing GLYCINE
human immunoglobulin g drug variants not containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring AG | human immunoglobulin g | 44206-417 |
| CSL Behring AG | human immunoglobulin g | 44206-436 |
| CSL Behring AG | human immunoglobulin g | 44206-451 |
| >Company | >Ingredient | >NDC |
Excipient focus: HUMAN IMMUNOGLOBULIN A
human immunoglobulin g drug variants containing HUMAN IMMUNOGLOBULIN A
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring AG | human immunoglobulin g | 44206-436 |
| CSL Behring AG | human immunoglobulin g | 44206-451 |
| >Company | >Ingredient | >NDC |
human immunoglobulin g drug variants not containing HUMAN IMMUNOGLOBULIN A
Excipient focus: POLYSORBATE 80
human immunoglobulin g drug variants containing POLYSORBATE 80
human immunoglobulin g drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring AG | human immunoglobulin g | 44206-417 |
| CSL Behring AG | human immunoglobulin g | 44206-436 |
| GC Biopharma Corp | human immunoglobulin g | 61476-104 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROLINE
human immunoglobulin g drug variants containing PROLINE
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring AG | human immunoglobulin g | 44206-436 |
| CSL Behring AG | human immunoglobulin g | 44206-451 |
| >Company | >Ingredient | >NDC |
human immunoglobulin g drug variants not containing PROLINE
Excipient focus: SODIUM ACETATE
human immunoglobulin g drug variants containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Bio Products Laboratory Limited | human immunoglobulin g | 64208-8234 |
| >Company | >Ingredient | >NDC |
human immunoglobulin g drug variants not containing SODIUM ACETATE
Excipient focus: SODIUM CHLORIDE
human immunoglobulin g drug variants containing SODIUM CHLORIDE
human immunoglobulin g drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring AG | human immunoglobulin g | 44206-436 |
| CSL Behring AG | human immunoglobulin g | 44206-451 |
| GC Biopharma Corp | human immunoglobulin g | 61476-104 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
human immunoglobulin g drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Bio Products Laboratory Limited | human immunoglobulin g | 64208-8234 |
| >Company | >Ingredient | >NDC |
human immunoglobulin g drug variants not containing SORBITOL
Excipient focus: SUCROSE
human immunoglobulin g drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring AG | human immunoglobulin g | 44206-417 |
| >Company | >Ingredient | >NDC |
human immunoglobulin g drug variants not containing SUCROSE
Excipient focus: WATER
human immunoglobulin g drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| ADMA Biologics Inc | human immunoglobulin g | 59730-6502 |
| GC Biopharma Corp | human immunoglobulin g | 61476-104 |
| KEDRION BIOPHARMA INC | human immunoglobulin g | 76125-918 |
| >Company | >Ingredient | >NDC |
human immunoglobulin g drug variants not containing WATER
Excipient focus: WATER O-18
human immunoglobulin g drug variants containing WATER O-18
| Company | Ingredient | NDC |
|---|---|---|
| ADMA Biologics Inc | human immunoglobulin g | 69800-0250 |
| >Company | >Ingredient | >NDC |
human immunoglobulin g drug variants not containing WATER O-18
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch